Goldman Sachs’s Protalix BioTherapeutics PLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $151K | Sell |
102,178
-187,283
| -65% | -$277K | ﹤0.01% | 4800 |
|
|
2025
Q1 | $741K | Buy |
289,461
+239,751
| +482% | +$614K | ﹤0.01% | 4017 |
|
|
2024
Q4 | $93.5K | Sell |
49,710
-531
| -1% | -$998 | ﹤0.01% | 4788 |
|
|
2024
Q3 | $51.2K | Sell |
50,241
-411,717
| -89% | -$420K | ﹤0.01% | 4661 |
|
|
2024
Q2 | $540K | Buy |
461,958
+369,534
| +400% | +$432K | ﹤0.01% | 3914 |
|
|
2024
Q1 | $116K | Sell |
92,424
-12,052
| -12% | -$15.2K | ﹤0.01% | 4434 |
|
|
2023
Q4 | $186K | Sell |
104,476
-3,319
| -3% | -$5.91K | ﹤0.01% | 4350 |
|
|
2023
Q3 | $179K | Buy |
107,795
+57,601
| +115% | +$95.6K | ﹤0.01% | 4277 |
|
|
2023
Q2 | $100K | Buy |
+50,194
| New | +$100K | ﹤0.01% | 4563 |
|
|
2018
Q3 | – | Sell |
-2,845
| Closed | -$12K | – | 4216 |
|
|
2018
Q2 | $12K | Buy |
2,845
+1
| +0% | +$4 | ﹤0.01% | 4136 |
|
|
2018
Q1 | $15K | Sell |
2,844
-1
| -0% | -$5 | ﹤0.01% | 4158 |
|
|
2017
Q4 | $19K | Buy |
2,845
+1
| +0% | +$7 | ﹤0.01% | 4097 |
|
|
2017
Q3 | $16K | Buy |
+2,844
| New | +$16K | ﹤0.01% | 4205 |
|
|
2017
Q1 | – | Sell |
-4,062
| Closed | -$18K | – | 4509 |
|
|
2016
Q4 | $18K | Buy |
4,062
+8
| +0.2% | +$35 | ﹤0.01% | 4364 |
|
|
2016
Q3 | $23K | Hold |
4,054
| – | – | ﹤0.01% | 4427 |
|
|
2016
Q2 | $26K | Hold |
4,054
| – | – | ﹤0.01% | 4368 |
|
|
2016
Q1 | $34K | Sell |
4,054
-3,643
| -47% | -$30.6K | ﹤0.01% | 4292 |
|
|
2015
Q4 | $79K | Buy |
7,697
+6,432
| +508% | +$66K | ﹤0.01% | 4050 |
|
|
2015
Q3 | $15K | Buy |
+1,265
| New | +$15K | ﹤0.01% | 4488 |
|
|
2014
Q4 | – | Sell |
-2,835
| Closed | -$69K | – | 4639 |
|
|
2014
Q3 | $69K | Sell |
2,835
-4,099
| -59% | -$99.8K | ﹤0.01% | 4321 |
|
|
2014
Q2 | $253K | Buy |
6,934
+4,090
| +144% | +$149K | ﹤0.01% | 3828 |
|
|
2014
Q1 | $130K | Sell |
2,844
-30
| -1% | -$1.37K | ﹤0.01% | 4086 |
|
|
2013
Q4 | $112K | Sell |
2,874
-3,172
| -52% | -$124K | ﹤0.01% | 4058 |
|
|
2013
Q3 | $274K | Buy |
6,046
+2,005
| +50% | +$90.9K | ﹤0.01% | 3667 |
|
|
2013
Q2 | $198K | Buy |
+4,041
| New | +$198K | ﹤0.01% | 3637 |
|